Jacobs Levy Equity Management
INSP icon

Jacobs Levy Equity Management’s Inspire Medical Systems INSP Stock Holding History

Jacobs Levy Equity Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-110,594
Closed -$17.6M – 1101
2025
Q1 		$17.6M Sell
110,594
-99,566
-47% -$18M 0.07% 245
2024
Q4 		$39M Buy
210,160
+188,492
+870% +$36.6M 0.14% 152
2024
Q3 		$4.57M Sell
21,668
-3,047
-12% -$529K 0.02% 455
2024
Q2 		$3.31M Buy
24,715
+3,697
+18% +$700K 0.01% 511
2024
Q1 		$4.51M Buy
+21,018
New +$4.12M 0.02% 448
2023
Q4 		– Sell
-25,559
Closed -$5.07M – 1021
2023
Q3 		$5.07M Sell
25,559
-3,585
-12% -$904K 0.03% 374
2023
Q2 		$9.46M Sell
29,144
-1,464
-5% -$418K 0.05% 284
2023
Q1 		$7.16M Sell
30,608
-45,330
-60% -$11.5M 0.04% 336
2022
Q4 		$19.1M Sell
75,938
-13,269
-15% -$2.83M 0.13% 197
2022
Q3 		$15.8M Buy
+89,207
New +$17.9M 0.13% 198
2021
Q3 		– Sell
-2,735
Closed -$529K – 1080
2021
Q2 		$529K Sell
2,735
-19,228
-88% -$3.81M ﹤0.01% 850
2021
Q1 		$4.55M Sell
21,963
-1,429
-6% -$304K 0.04% 432
2020
Q4 		$4.4M Sell
23,392
-2,000
-8% -$327K 0.04% 417
2020
Q3 		$3.28M Sell
25,392
-2,698
-10% -$297K 0.03% 430
2020
Q2 		$2.44M Sell
28,090
-3,611
-11% -$278K 0.03% 483
2020
Q1 		$1.91M Buy
31,701
+8,291
+35% +$614K 0.02% 484
2019
Q4 		$1.74M Sell
23,410
-9,230
-28% -$593K 0.02% 571
2019
Q3 		$1.99M Sell
32,640
-460
-1% -$30.3K 0.02% 512
2019
Q2 		$2.01M Buy
33,100
+13,900
+72% +$749K 0.03% 522
2019
Q1 		$1.09M Buy
+19,200
New +$1.04M 0.02% 640

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Jacobs Levy Equity Management's INSP Position: Q2 2025 in Review

Jacobs Levy Equity Management sold out of Inspire Medical Systems (INSP) in Q2 2025, closing a stake of 110,594 shares — an estimated $17.6M sold.

Jacobs Levy Equity Management first reported a position in INSP in Q1 2019 and held it in 20 quarters. The position peaked at $39M in Q4 2024. 356 funds tracked by Wall St. Rank hold INSP as of Q2 2025.

  • Jacobs Levy Equity Management reported no remaining Inspire Medical Systems position as of Q2 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 110,594 Inspire Medical Systems shares in Q2 2025, an estimated $17.6M.
  • Jacobs Levy Equity Management first reported a position in Inspire Medical Systems in Q1 2019 and held it in 20 quarters.
  • Jacobs Levy Equity Management's Inspire Medical Systems position peaked at $39M in Q4 2024.
  • 356 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2025, filed 14 Aug 2025.